Hinge Health Reports Strong Q4 2025 Earnings with 46% Revenue Growth
- Significant Revenue Growth: Hinge Health reported $171 million in Q4 revenue, a 46% year-over-year increase, with full-year revenue reaching $588 million, reflecting a 51% growth compared to 2024, showcasing strong momentum in the digital health sector.
- Expanded Client Base: By the end of 2025, the company had over 2,800 clients covering nearly 25 million contracted lives, with 53% of clients from the Fortune 100, indicating a significant penetration among large enterprises.
- Effective AI Tools: The rollout of the AI assistant Robin resulted in a 28% reduction in care team time per asynchronous session, while achieving a 92% member satisfaction rating, which not only improved service efficiency but also enhanced customer loyalty.
- Optimistic Future Outlook: The CFO projected Q1 2026 revenue to be between $171 million and $173 million, representing a 39% year-over-year growth, with full-year revenue guidance of $732 million to $742 million, reflecting strong confidence in future growth.
Trade with 70% Backtested Accuracy
Analyst Views on HNGE
About HNGE
About the author
HINGE HEALTH REPORTS Q4 NON-GAAP DILUTED EARNINGS PER SHARE OF $0.49
- Financial Performance: Hinge Health reported a Q4 non-GAAP diluted net income per share of $0.49.
- Market Position: The company continues to strengthen its position in the digital health sector, focusing on innovative solutions for musculoskeletal care.
HINGE HEALTH INC Reports Q4 Earnings Per Share of USD 0.37
Health Insights: The article discusses recent trends and statistics in health, focusing on various health metrics and their implications for public health.
Economic Impact: It highlights the economic factors influencing health outcomes, including healthcare spending and its correlation with health improvements.
Policy Recommendations: The piece suggests policy changes aimed at enhancing health services and addressing disparities in healthcare access.
Future Projections: It concludes with predictions about future health trends and the potential challenges that may arise in the healthcare sector.
Hinge Health Reports Strong Q4 2025 Earnings with 46% Revenue Growth
- Significant Revenue Growth: Hinge Health reported $171 million in Q4 revenue, a 46% year-over-year increase, with full-year revenue reaching $588 million, reflecting a 51% growth compared to 2024, showcasing strong momentum in the digital health sector.
- Expanded Client Base: By the end of 2025, the company had over 2,800 clients covering nearly 25 million contracted lives, with 53% of clients from the Fortune 100, indicating a significant penetration among large enterprises.
- Effective AI Tools: The rollout of the AI assistant Robin resulted in a 28% reduction in care team time per asynchronous session, while achieving a 92% member satisfaction rating, which not only improved service efficiency but also enhanced customer loyalty.
- Optimistic Future Outlook: The CFO projected Q1 2026 revenue to be between $171 million and $173 million, representing a 39% year-over-year growth, with full-year revenue guidance of $732 million to $742 million, reflecting strong confidence in future growth.
Analysis of After-Hours Trading Performance of Multiple Companies
- Robinhood Revenue Decline: Robinhood's Q4 revenue of $1.28 billion fell short of the $1.34 billion expected by analysts, with transaction revenue also missing at $776 million, leading to a 7% drop in stock price, reflecting market concerns over its profitability.
- Lyft's Poor Performance: Lyft's stock dropped 15%, as its Q4 bookings of $5.07 billion met expectations, but its first-quarter adjusted EBITDA guidance of $120 million to $140 million fell short of the $139.8 million consensus, indicating pressure on profitability.
- Mattel's Disappointing Guidance: Mattel's stock plummeted 25%, with full-year adjusted earnings guidance ranging from $1.18 to $1.30 per share, significantly below the $1.77 expected by the market, and Q4 results also missed expectations, highlighting weakness in the toy market.
- Cloudflare's Strong Outlook: Cloudflare's stock surged 10% after projecting Q1 revenue between $620 million and $621 million, exceeding the $614 million consensus, and its Q4 results also surpassed analyst expectations, showcasing strong growth potential in the cloud networking market.
Bullish Charts Highlight These Healthcare Stocks: GE Healthcare, STERIS, and Hinge Health
Healthcare Stocks Momentum: Several non-biotech healthcare stocks are gaining momentum, breaking out of bases and establishing themselves as leaders in the sector.
Technical Indicators: These stocks are showing improving volume patterns, accelerating relative strength, and clean technical setups, indicating strong performance potential.
Market Rotation: As buyers shift focus to areas with sustained upside, these healthcare stocks are well-positioned to continue their upward trajectory.
Future Performance Outlook: The current trends suggest that these medical technology, services, and equipment stocks could deliver standout performance in the coming weeks.
Is Hinge Health Inc. (HNGE) Poised for a 29.59% Increase to Meet Wall Street Analysts' Expectations?
Stock Performance and Analyst Predictions: Hinge Health Inc. (HNGE) shares have increased by 0.9% recently, with Wall Street analysts projecting a mean price target of $64.86, suggesting a potential upside of 29.6% from the current price of $50.05.
Earnings Estimates and Analyst Agreement: There is strong consensus among analysts regarding HNGE's earnings prospects, with a 4.6% increase in the Zacks Consensus Estimate over the past month, indicating a positive outlook for the stock.
Skepticism Towards Price Targets: While price targets can provide insights, they should be approached with caution as they often mislead investors; analysts may set inflated targets due to business incentives.
Investment Strategy Considerations: Investors are advised to consider a range of factors beyond price targets, including earnings estimate revisions and the company's Zacks Rank #2 (Buy), to make informed investment decisions.
HINGE HEALTH REPORTS Q4 NON-GAAP DILUTED EARNINGS PER SHARE OF $0.49
- Financial Performance: Hinge Health reported a Q4 non-GAAP diluted net income per share of $0.49.
- Market Position: The company continues to strengthen its position in the digital health sector, focusing on innovative solutions for musculoskeletal care.
HINGE HEALTH INC Reports Q4 Earnings Per Share of USD 0.37
Health Insights: The article discusses recent trends and statistics in health, focusing on various health metrics and their implications for public health.
Economic Impact: It highlights the economic factors influencing health outcomes, including healthcare spending and its correlation with health improvements.
Policy Recommendations: The piece suggests policy changes aimed at enhancing health services and addressing disparities in healthcare access.
Future Projections: It concludes with predictions about future health trends and the potential challenges that may arise in the healthcare sector.
Hinge Health Reports Strong Q4 2025 Earnings with 46% Revenue Growth
- Significant Revenue Growth: Hinge Health reported $171 million in Q4 revenue, a 46% year-over-year increase, with full-year revenue reaching $588 million, reflecting a 51% growth compared to 2024, showcasing strong momentum in the digital health sector.
- Expanded Client Base: By the end of 2025, the company had over 2,800 clients covering nearly 25 million contracted lives, with 53% of clients from the Fortune 100, indicating a significant penetration among large enterprises.
- Effective AI Tools: The rollout of the AI assistant Robin resulted in a 28% reduction in care team time per asynchronous session, while achieving a 92% member satisfaction rating, which not only improved service efficiency but also enhanced customer loyalty.
- Optimistic Future Outlook: The CFO projected Q1 2026 revenue to be between $171 million and $173 million, representing a 39% year-over-year growth, with full-year revenue guidance of $732 million to $742 million, reflecting strong confidence in future growth.
Analysis of After-Hours Trading Performance of Multiple Companies
- Robinhood Revenue Decline: Robinhood's Q4 revenue of $1.28 billion fell short of the $1.34 billion expected by analysts, with transaction revenue also missing at $776 million, leading to a 7% drop in stock price, reflecting market concerns over its profitability.
- Lyft's Poor Performance: Lyft's stock dropped 15%, as its Q4 bookings of $5.07 billion met expectations, but its first-quarter adjusted EBITDA guidance of $120 million to $140 million fell short of the $139.8 million consensus, indicating pressure on profitability.
- Mattel's Disappointing Guidance: Mattel's stock plummeted 25%, with full-year adjusted earnings guidance ranging from $1.18 to $1.30 per share, significantly below the $1.77 expected by the market, and Q4 results also missed expectations, highlighting weakness in the toy market.
- Cloudflare's Strong Outlook: Cloudflare's stock surged 10% after projecting Q1 revenue between $620 million and $621 million, exceeding the $614 million consensus, and its Q4 results also surpassed analyst expectations, showcasing strong growth potential in the cloud networking market.
Bullish Charts Highlight These Healthcare Stocks: GE Healthcare, STERIS, and Hinge Health
Healthcare Stocks Momentum: Several non-biotech healthcare stocks are gaining momentum, breaking out of bases and establishing themselves as leaders in the sector.
Technical Indicators: These stocks are showing improving volume patterns, accelerating relative strength, and clean technical setups, indicating strong performance potential.
Market Rotation: As buyers shift focus to areas with sustained upside, these healthcare stocks are well-positioned to continue their upward trajectory.
Future Performance Outlook: The current trends suggest that these medical technology, services, and equipment stocks could deliver standout performance in the coming weeks.
Is Hinge Health Inc. (HNGE) Poised for a 29.59% Increase to Meet Wall Street Analysts' Expectations?
Stock Performance and Analyst Predictions: Hinge Health Inc. (HNGE) shares have increased by 0.9% recently, with Wall Street analysts projecting a mean price target of $64.86, suggesting a potential upside of 29.6% from the current price of $50.05.
Earnings Estimates and Analyst Agreement: There is strong consensus among analysts regarding HNGE's earnings prospects, with a 4.6% increase in the Zacks Consensus Estimate over the past month, indicating a positive outlook for the stock.
Skepticism Towards Price Targets: While price targets can provide insights, they should be approached with caution as they often mislead investors; analysts may set inflated targets due to business incentives.
Investment Strategy Considerations: Investors are advised to consider a range of factors beyond price targets, including earnings estimate revisions and the company's Zacks Rank #2 (Buy), to make informed investment decisions.
